KIEV, Aug. 22 – The development of transplantology in Ukraine is expected to pick up after the adoption of the law on transplantation prompts Ukrainian pharmaceutical manufacturers to organize production of immunosuppressors that patients have to take after transplantation, said Iryna Sysoyenko, deputy head of the parliamentary healthcare committee.

She said that the final result of transplantation development depends on the quality and quantity of immunosuppressors. Transplantation is not only a successful surgery. It also will maintain the health of patients.